{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:55:05Z","timestamp":1789682105129,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T00:00:00Z","timestamp":1318636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00701-011-1199-7","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T08:12:17Z","timestamp":1318579937000},"page":"211-222","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis"],"prefix":"10.1007","volume":"154","author":[{"given":"Gregorio","family":"Catal\u00e1n-Uribarrena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaizka","family":"Bilbao-Barandica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Pomposo-Gaztelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Undabeitia-Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"Ruiz de Gopegui-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Galbarriatu-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Canales-Llantada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Aurrecoechea-Obieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Igartua-Azkune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Carbayo-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,15]]},"reference":[{"key":"1199_CR1","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1200\/jco.2007.25.18_suppl.2068","volume":"25","author":"ML Affronti","year":"2007","unstructured":"Affronti ML, Day JM, Herndon JE II, Rich JN, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, McLendon RE, Friedman HS (2007) Radiation and concurrent temozolomide followed by rotational multi-agent chemotherapy for glioblastoma (GBM) patients. J Clin Oncol (Meeting Abstracts) 25:2068","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"1199_CR2","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1002\/cncr.24398","volume":"115","author":"ML Affronti","year":"2009","unstructured":"Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS (2009) Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 115:3501\u20133511","journal-title":"Cancer"},{"key":"1199_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1227\/00006123-199401000-00008","volume":"34","author":"FK Albert","year":"1994","unstructured":"Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45\u201360, discussion 60-41","journal-title":"Neurosurgery"},{"key":"1199_CR4","unstructured":"Asher A (2007) Prospective Analysis of Temozolomide as Adjuvant to Gliadel and Radiation in Newly Diagnosed Malignant Glioma. American Association of Neurological Surgeons Annual Meeting; April 14-19, 2007; Washington, DC. Abstract 42860. American Association of Neurological Surgeons Annual Meeting; April 14-19, 2007; Washington, DC. Abstract 42860. Washington, DC, p Oral communication"},{"key":"1199_CR5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2005.00.331","volume":"23","author":"H Athanassiou","year":"2005","unstructured":"Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P (2005) Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23:2372\u20132377","journal-title":"J Clin Oncol"},{"key":"1199_CR6","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","volume":"15","author":"FJ Attenello","year":"2008","unstructured":"Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15:2887\u20132893","journal-title":"Ann Surg Oncol"},{"key":"1199_CR7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/02688690802182256","volume":"22","author":"GM Barbagallo","year":"2008","unstructured":"Barbagallo GM, Jenkinson MD, Brodbelt AR (2008) \u2018Recurrent\u2019 glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452\u2013455","journal-title":"Br J Neurosurg"},{"key":"1199_CR8","first-page":"11","volume":"27","author":"M Brada","year":"2000","unstructured":"Brada M, Yung WK (2000) Clinical trial end points in malignant glioma: need for effective trial design strategy. Semin Oncol 27:11\u201319","journal-title":"Semin Oncol"},{"key":"1199_CR9","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","volume":"26","author":"AA Brandes","year":"2008","unstructured":"Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192\u20132197","journal-title":"J Clin Oncol"},{"key":"1199_CR10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1215\/15228517-2006-005","volume":"8","author":"AA Brandes","year":"2006","unstructured":"Brandes AA, Nicolardi L, Tosoni A, Gardiman M, Iuzzolino P, Ghimenton C, Reni M, Rotilio A, Sotti G, Ermani M (2006) Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma. Neuro Oncol 8:253\u2013260","journal-title":"Neuro Oncol"},{"key":"1199_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453\u2013461","journal-title":"Lancet Oncol"},{"key":"1199_CR12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345:1008\u20131012","journal-title":"Lancet"},{"key":"1199_CR13","unstructured":"CBTRUS (2007) Annual Report. Published by the Central Brain Tumor Registry of the United States, 2007"},{"key":"1199_CR14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887\u20131892","journal-title":"N Engl J Med"},{"key":"1199_CR15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","volume":"85","author":"WJ Curran Jr","year":"1993","unstructured":"Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704\u2013710","journal-title":"J Natl Cancer Inst"},{"key":"1199_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nurt.2009.05.002","volume":"6","author":"S Cha","year":"2009","unstructured":"Cha S (2009) Neuroimaging in neuro-oncology. Neurotherapeutics 6:465\u2013477","journal-title":"Neurotherapeutics"},{"key":"1199_CR17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1016035229961","volume":"13","author":"W Dang","year":"1996","unstructured":"Dang W, Daviau T, Brem H (1996) Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm Res 13:683\u2013691","journal-title":"Pharm Res"},{"key":"1199_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.WNL.0000133398.11870.9A","volume":"63","author":"MC Wit de","year":"2004","unstructured":"de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63:535\u2013537","journal-title":"Neurology"},{"key":"1199_CR19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0142-9612(95)98902-Q","volume":"16","author":"AJ Domb","year":"1995","unstructured":"Domb AJ, Rock M, Perkin C, Yipchuck G, Broxup B, Villemure JG (1995) Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials 16:1069\u20131072","journal-title":"Biomaterials"},{"key":"1199_CR20","unstructured":"Garibi JM, Catal\u00e1n G (2009) Gliadel en el mundo. Carmustina. Clinical Facts 2008. Publicaciones Permanyer Barcelona, pp 37\u201351"},{"key":"1199_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","volume":"9","author":"T Gorlia","year":"2008","unstructured":"Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981\/CE.3. Lancet Oncol 9:29\u201338","journal-title":"Lancet Oncol"},{"key":"1199_CR22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3171\/jns.1992.76.4.0640","volume":"76","author":"SA Grossman","year":"1992","unstructured":"Grossman SA, Reinhard C, Colvin OM, Chasin M, Brundrett R, Tamargo RJ, Brem H (1992) The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J Neurosurg 76:640\u2013647","journal-title":"J Neurosurg"},{"key":"1199_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(02)00853-7","volume":"3","author":"T Gupta","year":"2002","unstructured":"Gupta T, Sarin R (2002) Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol 3:557\u2013564","journal-title":"Lancet Oncol"},{"key":"1199_CR24","first-page":"246","volume":"3","author":"S Gururangan","year":"2001","unstructured":"Gururangan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JE 2nd, Provenzale JM, McLendon RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH, Friedman HS (2001) Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol 3:246\u2013250","journal-title":"Neuro Oncol"},{"key":"1199_CR25","doi-asserted-by":"crossref","unstructured":"Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K (2008) Chemotherapeutic wafers for High Grade Glioma. Cochrane Database Syst Rev :CD007294","DOI":"10.1002\/14651858.CD007294"},{"key":"1199_CR26","doi-asserted-by":"crossref","unstructured":"Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K (2008) Temozolomide for high grade glioma. Cochrane Database Syst Rev:CD007415","DOI":"10.1002\/14651858.CD007415"},{"key":"1199_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-7622-2-8","volume":"2","author":"A Hartz","year":"2005","unstructured":"Hartz A, Bentler S, Charlton M, Lanska D, Butani Y, Soomro GM, Benson K (2005) Assessing observational studies of medical treatments. Emerg Themes Epidemiol 2:8","journal-title":"Emerg Themes Epidemiol"},{"key":"1199_CR28","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1200\/jco.2006.24.18_suppl.11504","volume":"24","author":"CR Heery","year":"2006","unstructured":"Heery CR, Desjardins A, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ, Friedman AH, Reardon DA, Friedman HS (2006) Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma. J Clin Oncol (Meeting Abstracts) 24:11504","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"1199_CR29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3171\/jns.1979.50.5.0624","volume":"50","author":"WF Hoffman","year":"1979","unstructured":"Hoffman WF, Levin VA, Wilson CB (1979) Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg 50:624\u2013628","journal-title":"J Neurosurg"},{"key":"1199_CR30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00066-009-2015-7","volume":"185","author":"G Iliadis","year":"2009","unstructured":"Iliadis G, Selviaridis P, Kalogera-Fountzila A, Fragkoulidi A, Baltas D, Tselis N, Chatzisotiriou A, Misailidou D, Zamboglou N, Fountzilas G (2009) The Importance of Tumor Volume in the Prognosis of Patients with Glioblastoma. Strahlenther Onkol 185:743\u2013750","journal-title":"Strahlenther Onkol"},{"key":"1199_CR31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/02688690701642020","volume":"21","author":"MD Jenkinson","year":"2007","unstructured":"Jenkinson MD, Du Plessis DG, Walker C, Smith TS (2007) Advanced MRI in the management of adult gliomas. Br J Neurosurg 21:550\u2013561","journal-title":"Br J Neurosurg"},{"key":"1199_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/CNV-120027575","volume":"22","author":"LR Kleinberg","year":"2004","unstructured":"Kleinberg LR, Weingart J, Burger P, Carson K, Grossman SA, Li K, Olivi A, Wharam MD, Brem H (2004) Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest 22:1\u20139","journal-title":"Cancer Invest"},{"key":"1199_CR33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.27.8.1304","volume":"27","author":"RU Kothari","year":"1996","unstructured":"Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304\u20131305","journal-title":"Stroke"},{"key":"1199_CR34","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/00006123-199711000-00004","volume":"41","author":"A Kowalczuk","year":"1997","unstructured":"Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL (1997) Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41:1028\u20131036, discussion 1036-1028","journal-title":"Neurosurgery"},{"key":"1199_CR35","doi-asserted-by":"crossref","unstructured":"Krzeminski JP, Piquer J, Riesgo P (2008) Repeated Implantation of Interstitial Chemotherapy to Treat Malignant Gliomas. Neurosurgery Quarterly 18:286\u2013289 210.1097\/WNQ.1090b1013e3181823144","DOI":"10.1097\/WNQ.0b013e3181823144"},{"key":"1199_CR36","first-page":"445","volume":"8","author":"RV Rocca La","year":"2006","unstructured":"La Rocca RV, Hodes J, Villanueva WG, Vitaz TW, Morassutti DJ, Doyle MJ, Glisson S, Cervera A, Stribinskiene L, New P, Litofsky NS (2006) A phase II study of radiation with concomitant and then sequential temozolamide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgey with carmustine (BCNU) wafer insertion (Abstract TA-28). Neuro Oncol 8:445","journal-title":"Neuro Oncol"},{"key":"1199_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1185\/03007990802611935","volume":"25","author":"RV Rocca La","year":"2009","unstructured":"La Rocca RV, Mehdorn HM (2009) Localized BCNU chemotherapy and the multimodal management of malignant glioma. Curr Med Res Opin 25:149\u2013160","journal-title":"Curr Med Res Opin"},{"key":"1199_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190\u2013198","journal-title":"J Neurosurg"},{"key":"1199_CR39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00701-009-0185-9","volume":"151","author":"F Lefranc","year":"2009","unstructured":"Lefranc F (2009) Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas. Acta Neurochir (Wien) 151:109\u2013112","journal-title":"Acta Neurochir (Wien)"},{"key":"1199_CR40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14737140.8.3.343","volume":"8","author":"SH Lin","year":"2008","unstructured":"Lin SH, Kleinberg LR (2008) Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. Expert Rev Anticancer Ther 8:343\u2013359","journal-title":"Expert Rev Anticancer Ther"},{"key":"1199_CR41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2001.19.2.509","volume":"19","author":"M.R.C.B.T.P.","year":"2001","unstructured":"M.R.C.B.T.P. (2001) Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 19:509\u2013518","journal-title":"J Clin Oncol"},{"key":"1199_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/2008.4.17536","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa AR (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156\u2013162","journal-title":"J Neurosurg"},{"key":"1199_CR43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2008.5.17557","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quinones-Hinojosa A (2009) Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 110:583\u2013588","journal-title":"J Neurosurg"},{"key":"1199_CR44","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","volume":"24","author":"RO Mirimanoff","year":"2006","unstructured":"Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563\u20132569","journal-title":"J Clin Oncol"},{"key":"1199_CR45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3171\/jns.1990.73.3.0331","volume":"73","author":"JM Nazzaro","year":"1990","unstructured":"Nazzaro JM, Neuwelt EA (1990) The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331\u2013344","journal-title":"J Neurosurg"},{"key":"1199_CR46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10143-003-0280-y","volume":"26","author":"M Ohki","year":"2003","unstructured":"Ohki M, Sakurada K, Sonoda Y, Sato S, Saito S, Kayama T (2003) Analysis of the extent of astrocytic tumour resection evaluated by magnetic resonance images. Neurosurg Rev 26:262\u2013265","journal-title":"Neurosurg Rev"},{"key":"1199_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1130-1473(01)70716-6","volume":"12","author":"JV Pesudo Mart\u00ednez","year":"2001","unstructured":"Pesudo Mart\u00ednez JV, Gonz\u00e1lez-Darder JM, Feli\u00fa Tatay R, Belloch Ugarte V, Vera Roman J, Gil Sal\u00fa JL (2001) Assessment of the degree of resection of high grade supratentorial gliomas with early postoperative magnetic resonance. Neurocirugia (Astur) 12:43\u201350","journal-title":"Neurocirugia (Astur)"},{"key":"1199_CR48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1215\/15228517-2008-052","volume":"10","author":"U Pichlmeier","year":"2008","unstructured":"Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025\u20131034","journal-title":"Neuro Oncol"},{"key":"1199_CR49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0093-7754(01)90068-5","volume":"28","author":"M Prados","year":"2001","unstructured":"Prados M (2001) Temozolomide in combination with other cytotoxic agents. Semin Oncol 28:24\u201333","journal-title":"Semin Oncol"},{"key":"1199_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clineuro.2004.02.025","volume":"107","author":"MA Proescholdt","year":"2005","unstructured":"Proescholdt MA, Macher C, Woertgen C, Brawanski A (2005) Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg 107:95\u201398","journal-title":"Clin Neurol Neurosurg"},{"key":"1199_CR51","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1200\/jco.2008.26.15_suppl.13003","volume":"26","author":"T Ryken","year":"2008","unstructured":"Ryken T, Carlisle T, Buatti J, Kirby P, Maley J, Hohl R, Smith BJ, Greenlee J, Frees M, Rogers M (2008) Treatment of adults with newly diagnosed glioblastoma multiforme or anaplastic astrocytoma with surgery, gliadel wafers and limited field radiation plus concomitant temozolomide followed by adjuvant temozolomide. J Clin Oncol (Meeting Abstracts) 26:13003","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"1199_CR52","doi-asserted-by":"crossref","unstructured":"Sabel M, Giese A (2008) Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin","DOI":"10.1185\/03007990802508180"},{"key":"1199_CR53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","volume":"62","author":"N Sanai","year":"2008","unstructured":"Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753\u2013764, discussion 264-756","journal-title":"Neurosurgery"},{"key":"1199_CR54","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00006123-199805000-00054","volume":"42","author":"R Sawaya","year":"1998","unstructured":"Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044\u20131055, discussion 1055-1046","journal-title":"Neurosurgery"},{"key":"1199_CR55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL (2009) From randomized controlled trials to observational studies. Am J Med 122:114\u2013120","journal-title":"Am J Med"},{"key":"1199_CR56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00023210-200721090-00006","volume":"21","author":"BM Spiegel","year":"2007","unstructured":"Spiegel BM, Esrailian E, Laine L, Chamberlain MC (2007) Clinical impact of adjuvant chemotherapy in glioblastoma multiforme: a meta-analysis. CNS Drugs 21:775\u2013787","journal-title":"CNS Drugs"},{"key":"1199_CR57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3171\/jns.2000.93.6.1003","volume":"93","author":"W Stummer","year":"2000","unstructured":"Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003\u20131013","journal-title":"J Neurosurg"},{"key":"1199_CR58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401","journal-title":"Lancet Oncol"},{"key":"1199_CR59","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1227\/01.neu.0000317304.31579.17","volume":"62","author":"W Stummer","year":"2008","unstructured":"Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564\u2013576, discussion 564-576","journal-title":"Neurosurgery"},{"key":"1199_CR60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"1199_CR61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"1199_CR62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41:44\u201348, discussion 48-49","journal-title":"Neurosurgery"},{"key":"1199_CR63","doi-asserted-by":"crossref","unstructured":"Van den Bent MJ, Stupp R, Mason W (2005) Impact of the extent of resection on overall survival in newly diagnosed glioblastoma after chemo-irradiation with temozolamide: further analysis of EORTC study 26981. Eur J Cancer Suppl 3:134 (abstr)","DOI":"10.1016\/S1359-6349(05)80779-7"},{"key":"1199_CR64","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","volume":"5","author":"MD Walker","year":"1979","unstructured":"Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725\u20131731","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1199_CR65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","volume":"5","author":"M Westphal","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79\u201388","journal-title":"Neuro Oncol"},{"key":"1199_CR66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","volume":"148","author":"M Westphal","year":"2006","unstructured":"Westphal M, Ram Z, Riddle V, Hilt D, Bortey E (2006) Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269\u2013275, discussion 275","journal-title":"Acta Neurochir (Wien)"},{"key":"1199_CR67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jbm.820280314","volume":"28","author":"MP Wu","year":"1994","unstructured":"Wu MP, Tamada JA, Brem H, Langer R (1994) In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res 28:387\u2013395","journal-title":"J Biomed Mater Res"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-011-1199-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-011-1199-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-011-1199-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:24:22Z","timestamp":1593131062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-011-1199-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,15]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1007\/s00701-011-1199-7","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,15]]}}}